In non-neuroendocrine lung cancer cells treated with etoposide, loss of YAP increases GSDME expression levels, switches the cell death route from apoptosis to pyroptosis, and sensitizes tumor cells to etoposide (59). The gene discussed is GSDME; the disease is neoplasm.